Cytocybernetics

About:

Cytocybernetics is a Biotechnology which specializes in cellular electrophysiology

Top Investors: National Science Foundation, University at Buffalo, 43North, NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR)

Description:

Cytocybernetics specializes in cellular electrophysiology. They developed the Cybercyte, which is a very powerful, but user friendly, plug and play dynamic clamp system. They offer a complete range of CRO services, including FDA mandated drug safety screening, custom electrophysiology, custom modelling, and custom analysis.

Total Funding Amount:

$2.77M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Buffalo, New York, United States

Founded Date:

2013-01-01

Founders:

Glenna Bett, Randall Rasmusson

Number of Employees:

1-10

Last Funding Date:

2022-02-24

IPO Status:

Private

Industries: